PH12014000105A1 - Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds - Google Patents
Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compoundsInfo
- Publication number
- PH12014000105A1 PH12014000105A1 PH12014000105A PH12014000105A PH12014000105A1 PH 12014000105 A1 PH12014000105 A1 PH 12014000105A1 PH 12014000105 A PH12014000105 A PH 12014000105A PH 12014000105 A PH12014000105 A PH 12014000105A PH 12014000105 A1 PH12014000105 A1 PH 12014000105A1
- Authority
- PH
- Philippines
- Prior art keywords
- compositions
- therapeutic methods
- treating diabetes
- diterpenoid compounds
- diabetes utilizing
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- -1 diterpenoid compounds Chemical class 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010022491 Insulin resistant diabetes Diseases 0.000 abstract 1
- GCXIISSOWSXMCD-WOVZMQRJSA-N borapetoside A Natural products C[C@]12C[C@H](OC(=O)[C@@H]1C[C@@H]3OC(=O)[C@@]4(O)[C@@H](CC[C@H]2[C@]34C)O[C@H]5O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]5O)c6cocc6 GCXIISSOWSXMCD-WOVZMQRJSA-N 0.000 abstract 1
- GCXIISSOWSXMCD-MZYRCUENSA-N borapetoside a Chemical compound O([C@H]1CC[C@H]2[C@]3(C)C[C@H](OC(=O)[C@@H]3C[C@H]3[C@]2([C@@]1(O)C(=O)O3)C)C1=COC=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCXIISSOWSXMCD-MZYRCUENSA-N 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Steroid Compounds (AREA)
Abstract
The present invention is directed to therapeutic methods and compositions for treating insulin resistant diabetes or diabetes with inflammation in a subject comprising administering an effective amount of borapetoside A, or a pharmaceutically acceptable salt. metabolite, solvate or prodrug thereof, to said subject.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PH12014000105A PH12014000105A1 (en) | 2014-03-21 | 2014-03-21 | Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PH12014000105A PH12014000105A1 (en) | 2014-03-21 | 2014-03-21 | Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12014000105A1 true PH12014000105A1 (en) | 2015-09-28 |
Family
ID=55305148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12014000105A PH12014000105A1 (en) | 2014-03-21 | 2014-03-21 | Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds |
Country Status (1)
| Country | Link |
|---|---|
| PH (1) | PH12014000105A1 (en) |
-
2014
- 2014-03-21 PH PH12014000105A patent/PH12014000105A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202308496B (en) | Pharmaceutical compositions of therapeutically active compounds | |
| CL2015002164A1 (en) | Combined formulation of two antiviral compounds. | |
| PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
| PH12015502075B1 (en) | Treatment of cataplexy | |
| PH12016501788A1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
| MX385283B (en) | CANCER TREATMENT USING 2-DEOXY-2-FLUORO-L-FUCOSE IN COMBINATION WITH A CHECKPOINT INHIBITOR. | |
| EP3141603A4 (en) | Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective | |
| WO2014160281A3 (en) | Method of enhancing delivery of therapeutic compounds to the eye | |
| TW201613578A (en) | Pharmaceutical combinations | |
| MX2017006454A (en) | Sublingual administration of riluzole. | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| MX2017006446A (en) | Sublingual formulation of riluzole. | |
| MX2016016388A (en) | Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds. | |
| CL2016000397A1 (en) | Cancer treatment | |
| MX2021014120A (en) | Treatment of androgen deprivation therapy associated symptoms. | |
| WO2014153505A3 (en) | Treatment of chemotherapy-induced peripheral neuropathy | |
| PH12014000105A1 (en) | Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds | |
| IN2014DE00818A (en) | ||
| IN2014DE00822A (en) | ||
| MX2016010919A (en) | 4-benzylsulfonyl-2-butenenitrile. | |
| ZA201606135B (en) | Pharmaceutical compositions of therapeutically active compounds | |
| MD4458B1 (en) | Use of Polybiolin drug in patients with liver cirrhosis | |
| EA201592232A1 (en) | APPLICATION OF DENTSIKHIN IN OBTAINING A MEDICINE FOR THE TREATMENT OF THROMBOCYTOPIA |